Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinovac H1N1 Vaccines in Healthy Adults, Elders, Adolescents and Children
NCT00956111Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jul 2009
- Primary completion
- Sep 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of Panflu in influenza A H1N1 infection (H1N1), sponsored by Sinovac Biotech Ltd.. Started Jul 2009; status: completed.
02
Drugs
Panflu
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00956111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00956111.